$HZNP News Article - Target Enrollment Reached in MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA (pegloticase injection) Co-Prescribed with Methotrexate as an Immunomodulator to Enhance Response Rates for People Living with Uncontrolled Gout https://marketwirenews.com/news-releases/targ...73889.html